European Primary Care Cardiovascular Society

COVID-19

Management of diabetes during COVID-19 pandemic - practical recommendations

News - May 19, 2020

A consensus document by a group of representatives from primary and secondary care has been published on the management of diabetes for patients at risk or with confirmed COVID-19.

Hospitalized COVID-19 patients have a high risk of VTE

Literature - May 14, 2020 - Middeldorp S et al., - J Thromb Haemost 2020

Cumulative incidences of diagnosed and symptomatic VTE are increased in COVID-19 patients hospitalized in a Dutch hospital, with higher risk in those admitted to the ICU as compared to the general ward.

In ICU patients with COVID-19 pneumonia incidence of thrombotic complications is high

Literature - May 14, 2020 - Klok FA et al. - Thrombosis Research 2020
This observational study in 184 patients with COVID-19 pneumonia admitted to the ICU in the Netherlands showed a cumulative incidence of venous thromboembolism and arterial thrombotic complications of 31%.

This observational study in 184 patients with COVID-19 pneumonia admitted to the ICU in the Netherlands showed a cumulative incidence of venous thromboembolism and arterial thrombotic complications of 31%.

COVID-19, ACE2 and RAASi - a scientific perspective

10' education - May 14, 2020 - Prof. Jan Danser, PhD
This presentation is part of a webinar on COVID-19, ACE2 and RAAS inhibition and focuses on the scientific data that is available on the ACE2 receptor and RAAS inhibitors.

This presentation is part of a webinar on COVID-19, ACE2 and RAAS inhibition and focuses on the scientific data that is available on the ACE2 receptor and RAAS inhibitors.

COVID-19, ACE2 and RAASi - a clinical perspective

10' education - May 14, 2020 - Prof. Murray Epstein, MD
As part of a webinar on COVID-19, ACE2 and RAASi, prof. Epstein presents what the clinical implications are of discontinuation of RAASi in COVID-19 patients and strongly recommends to continue use of these medications.

As part of a webinar on COVID-19, ACE2 and RAASi, prof. Epstein presents what the clinical implications are of discontinuation of RAASi in COVID-19 patients and strongly recommends to continue use of these medications.

What are the implications for practice? - A discussion on COVID-19, ACE2 and RAASi

10' education - May 14, 2020 - Profs. John Deanfield, Jan Danser and Murray Epstein
As many questions arise on COVID-19, ACE2 and RAAS inhibition, 3 experts discuss some of the issues on this topic as part of a webinar.

As many questions arise on COVID-19, ACE2 and RAAS inhibition, 3 experts discuss some of the issues on this topic as part of a webinar.

Recommended use of RAS blockers during COVID-19

Literature - May 14, 2020 - Danser AHJ et al., - Hypertension 2020

This commentary article describes the function of ACE2, the receptor responsible for SARS-CoV-2 entry, and describes why continued use of RAS blockers during the COVID-19 pandemic is recommended.

Compared to 2019, increase in out-of-hospital cardiac arrests during the COVID-19 outbreak in Lombardia, Italy

Literature - May 11, 2020 - Baldi E, et al. - N Engl J Med 2020

In a letter to the editor, Baldi and colleagues describe a study on the incidence of out-of-hospital cardiac arrest in 4 provinces in Lombardy, Italy, during the initial outbreak of COVID-19.

Multiple potential mechanisms linking obesity to severe COVID-19

Literature - May 7, 2020 - Sattar N et al., - Circulation. 2020.

This article discusses obesity from a cardiovascular, cardiorespiratory and inflammatory perspective and describes how obesity could potentially contribute to severe COVID-19 illness.

Guidance on diagnosis and management of CVD in COVID-19 patients by ESC

News - Apr. 29, 2020
A guidance document, published by the ESC, provides recommendations on how to diagnose and manage CVD in COVID-19 patients and on other aspects of CV care during the outbreak.

A guidance document, published by the ESC, provides recommendations on how to diagnose and manage CVD in COVID-19 patients and on other aspects of CV care during the outbreak.

COVID-19 testing in primary care - a European survey

News - Apr. 15, 2020
A short survey among EPCCS Council members shows which persons are being tested for possible COVID-19 infection and whether GPs are involved in testing.

A short survey among EPCCS Council members shows which persons are being tested for possible COVID-19 infection and whether GPs are involved in testing.

Join now to collect CV data of COVID-19 patients in the CAPACITY COVID registry

News - Apr. 14, 2020
An initiative of cardiologists and the Dutch CardioVascular Alliance has resulted in the start of the CAPACITY COVID registry, to collect CV data of COVID-19 patients. The initiators call to join now

An initiative of cardiologists and the Dutch CardioVascular Alliance has resulted in the start of the CAPACITY COVID registry, to collect CV data of COVID-19 patients. The initiators call to join now!

COVID-19